Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

Similar articles for PubMed (Select 21349806)

1.
2.

The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.

Liu Z, Miers WR, Wei L, Barrett EJ.

Biochem Biophys Res Commun. 2000 Oct 5;276(3):1255-60.

PMID:
11027619
3.
5.

Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha.

Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WH.

Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E493-501. Epub 2004 Nov 2.

6.

The role of ubiquitin-proteasome system in ageing.

Löw P.

Gen Comp Endocrinol. 2011 May 15;172(1):39-43. doi: 10.1016/j.ygcen.2011.02.005. Epub 2011 Feb 13. Review.

PMID:
21324320
7.

Altered expression of genes regulating skeletal muscle mass in the portacaval anastomosis rat.

Dasarathy S, Muc S, Hisamuddin K, Edmison JM, Dodig M, McCullough AJ, Kalhan SC.

Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1105-13. Epub 2006 Dec 21.

9.

The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.

Tisdale MJ.

J Support Oncol. 2005 May-Jun;3(3):209-17. Review.

PMID:
15915823
10.

Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting.

Mitch WE, Bailey JL, Wang X, Jurkovitz C, Newby D, Price SR.

Am J Physiol. 1999 May;276(5 Pt 1):C1132-8.

11.

Ciliary neurotrophic factor upregulates ubiquitin-proteasome components in a rat model of neuronal injury.

Jho DH, Engelhard HH, Gandhi R, Chao J, Babcock T, Ong E, Espat NJ.

Cytokine. 2004 Sep 21;27(6):142-51.

PMID:
15304243
12.
13.

Molecular signaling pathways regulating muscle proteolysis during atrophy.

Franch HA, Price SR.

Curr Opin Clin Nutr Metab Care. 2005 May;8(3):271-5. Review.

PMID:
15809529
14.

Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.

Schulze PC, Fang J, Kassik KA, Gannon J, Cupesi M, MacGillivray C, Lee RT, Rosenthal N.

Circ Res. 2005 Sep 2;97(5):418-26. Epub 2005 Jul 28.

15.

Differential gene expression in the rat skeletal and heart muscle in glucocorticoid-induced myopathy: analysis by microarray.

Komamura K, Shirotani-Ikejima H, Tatsumi R, Tsujita-Kuroda Y, Kitakaze M, Miyatake K, Sunagawa K, Miyata T.

Cardiovasc Drugs Ther. 2003 Jul;17(4):303-10.

PMID:
14618091
16.

Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.

Lo HC, Hinton PS, Yang H, Unterman TG, Ney DM.

JPEN J Parenter Enteral Nutr. 1996 May-Jun;20(3):171-7.

PMID:
8776688
17.
18.

Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I).

Russell ST, Eley H, Tisdale MJ.

Cell Signal. 2007 Jul;19(7):1583-95. Epub 2007 Feb 21.

PMID:
17376652
19.

Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression.

Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J, Salehian B.

Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E363-71. Epub 2003 Apr 29.

20.

Glucose infusion suppresses surgery-induced muscle protein breakdown by inhibiting ubiquitin-proteasome pathway in rats.

Mikura M, Yamaoka I, Doi M, Kawano Y, Nakayama M, Nakao R, Hirasaka K, Okumura Y, Nikawa T.

Anesthesiology. 2009 Jan;110(1):81-8. doi: 10.1097/ALN.0b013e318190b6c1.

PMID:
19104174
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk